Your browser doesn't support javascript.
loading
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses.
Durand-Zaleski, Isabelle; Ducrocq, Gregory; Mimouni, Maroua; Frenkiel, Jerome; Avendano-Solá, Cristina; Gonzalez-Juanatey, Jose R; Ferrari, Emile; Lemesle, Gilles; Puymirat, Etienne; Berard, Laurence; Cachanado, Marine; Arnaiz, Joan Albert; Martínez-Sellés, Manuel; Silvain, Johanne; Ariza-Solé, Albert; Calvo, Gonzalo; Danchin, Nicolas; Paco, Sandra; Drouet, Elodie; Abergel, Helene; Rousseau, Alexandra; Simon, Tabassome; Steg, Philippe Gabriel.
Afiliación
  • Durand-Zaleski I; AP-HP Health Economics Research Unit, Hotel Dieu Hospital, place du parvis de Notre Dame 75004, Paris, France.
  • Ducrocq G; INSERM UMR 1153 CRESS, Paris, France.
  • Mimouni M; Université de Paris, AP-HP, French Alliance for Cardiovascular Trials (FACT), INSERM U1148, 75018, Paris, France.
  • Frenkiel J; AP-HP Health Economics Research Unit, Hotel Dieu Hospital, place du parvis de Notre Dame 75004, Paris, France.
  • Avendano-Solá C; AP-HP Health Economics Research Unit, Hotel Dieu Hospital, place du parvis de Notre Dame 75004, Paris, France.
  • Gonzalez-Juanatey JR; Clinical Pharmacology Service, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Ferrari E; Cardiology Department, University Hospital, IDIS, CIBERCV, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Lemesle G; Université Côte d'Azur, and CHU de Nice, Hôpital Pasteur 1, Service de Cardiologie, 06001, Nice, France.
  • Puymirat E; Institut Cœur Poumon, Centre Hospitalier Universitaire de Lille, Faculté de Médecine de Lille, Université de Lille, Institut Pasteur de Lille, Inserm U1011, F-59000 Lille, France.
  • Berard L; Université de Paris, AP-HP, Hôpital Européen Georges Pompidou, French Alliance for Cardiovascular Trials (FACT), 75015, Paris, France.
  • Cachanado M; Department of Clinical Pharmacology-Clinical Research Platform (URCEST-CRB-CRCEST), AP-HP, Hôpital Saint Antoine, French Alliance for Cardiovascular Trials (FACT), Sorbonne-Université, 75012, Paris, France.
  • Arnaiz JA; Department of Clinical Pharmacology-Clinical Research Platform (URCEST-CRB-CRCEST), AP-HP, Hôpital Saint Antoine, French Alliance for Cardiovascular Trials (FACT), Sorbonne-Université, 75012, Paris, France.
  • Martínez-Sellés M; Clinical Trials Unit, Clinical Pharmacology Department, Hospital Clinic, Barcelona, Spain.
  • Silvain J; Servicio de Cardiología, Hospital Universitario Gregorio Marañón, CIBERCV, and Universidad Europea, Universidad Complutense, Madrid, Spain.
  • Ariza-Solé A; Sorbonne Université, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), INSERM UMRS 1166, 75013, Paris, France.
  • Calvo G; University Hospital Bellvitge, Heart Disease Institute, Barcelona, Spain.
  • Danchin N; Àrea del Medicament, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Paco S; Université de Paris, AP-HP, Hôpital Européen Georges Pompidou, French Alliance for Cardiovascular Trials (FACT), 75015, Paris, France.
  • Drouet E; Department of Clinical Pharmacology-Clinical Research Platform (URCEST-CRB-CRCEST), AP-HP, Hôpital Saint Antoine, French Alliance for Cardiovascular Trials (FACT), Sorbonne-Université, 75012, Paris, France.
  • Abergel H; Department of Clinical Pharmacology-Clinical Research Platform (URCEST-CRB-CRCEST), AP-HP, Hôpital Saint Antoine, French Alliance for Cardiovascular Trials (FACT), Sorbonne-Université, 75012, Paris, France.
  • Rousseau A; Université de Paris, AP-HP, French Alliance for Cardiovascular Trials (FACT), INSERM U1148, 75018, Paris, France.
  • Simon T; Department of Clinical Pharmacology-Clinical Research Platform (URCEST-CRB-CRCEST), AP-HP, Hôpital Saint Antoine, French Alliance for Cardiovascular Trials (FACT), Sorbonne-Université, 75012, Paris, France.
  • Steg PG; Department of Clinical Pharmacology-Clinical Research Platform (URCEST-CRB-CRCEST), AP-HP, Hôpital Saint Antoine, French Alliance for Cardiovascular Trials (FACT), Sorbonne-Université, 75012, Paris, France.
Eur Heart J Qual Care Clin Outcomes ; 9(2): 194-202, 2023 02 28.
Article en En | MEDLINE | ID: mdl-35612990
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anemia / Infarto del Miocardio Tipo de estudio: Guideline / Health_economic_evaluation Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Eur Heart J Qual Care Clin Outcomes Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anemia / Infarto del Miocardio Tipo de estudio: Guideline / Health_economic_evaluation Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Eur Heart J Qual Care Clin Outcomes Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido